-5%
Sparfloxacin is a broad-spectrum fluoroquinolone antibacterial agent. It exerts its bactericidal effect by inhibiting bacterial enzymes DNA gyrase and topoisomerase IV, which are essential for DNA replication and repair.
It demonstrates enhanced in vitro activity against:
- Gram-positive organisms (e.g., Streptococcus pneumoniae, Staphylococcus aureus)
- Mycobacteria
- Chlamydia species
Saga is indicated for the treatment of adults (≥18 years) with infections caused by susceptible microorganisms, including:
- Community-Acquired Pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae, or Streptococcus pneumoniae
- Acute Bacterial Exacerbations of Chronic Bronchitis (ABECB) caused by organisms such as Enterobacter cloacae, Klebsiella pneumoniae, Staphylococcus aureus, and others
- Chronic Obstructive Pulmonary Disease (COPD)
- Acute Maxillary Sinusitis (AMS)
- Urinary Tract Infection (including gonococcal and non-gonococcal urethritis, chancroid, and other STDs)
- Bacterial prostatitis
- Bacterial diarrhea
- Osteomyelitis
Additional Uses:
- In combination therapy for Tuberculosis (with rifampicin and isoniazid)
- In multidrug regimens for Leprosy
⚠️ ঔষধটি অবশ্যই রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী গ্রহণ করতে হবে।